TET2 and chronic myelomonocytic leukemia: In our study, 18/26 (69%) aCML and 51/59 (86%) CMML cases harbor at least one mutation in the epigenetic modifier genes TET2, IDH1/2, DNMT3A, EZH2, and ASXL1 (Figure 1A,B).